Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by mdjbrownon Jan 24, 2024 12:32pm
82 Views
Post# 35843220

RE:RE:RE:NO news since Oct 2nd 2023

RE:RE:RE:NO news since Oct 2nd 2023Unfortunately unplugged1, the retail shareholder is of no real concern to big corporations trying to position themselves in any industry.  Frustrating as heck, but a sad reality.

I agree 100% with you that it appears there is an effort to keep Medipharm under the radar, and that has been the case for a couple years now.   Awards, updates, etc seem to be held back from promotion, but for what reason, only the insiders truly know.

As s1i says though, it just takes one well placed shot, and this will be trading at multiples of todays share price.

Way to much going on with this company, for something not to take off in the near term!   Does that coincide with year end / Q1 financials?

Who knows, but patience is definately a virtue holding this one!   

I have been tempted to jump to other well performing stocks for a quick gain and come right back, but have never pulled that trigger.

<< Previous
Bullboard Posts
Next >>